Other equities analysts have also recently issued research reports about the stock. SunTrust Banks set a $70.00 target price on shares of Exponent and gave the stock a buy rating in a report on Friday, July 19th. Zacks Investment Research cut Exponent from a buy rating to a hold rating in a report on Wednesday, September 18th. ValuEngine raised shares of Exponent from a sell rating to a hold rating in a research report on Wednesday, September 4th. Cantor Fitzgerald boosted their price objective on shares of Exponent from $64.00 to $73.00 and gave the company an overweight rating in a report on Friday, July 19th. Finally, DA Davidson started coverage on shares of Exponent in a report on Wednesday, August 28th. They set a neutral rating on the stock. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, two have issued a buy rating and one has issued a strong buy rating to the company’s stock. Exponent has an average rating of Hold and a consensus target price of $76.75.
NASDAQ:EXPO traded up $0.37 during mid-day trading on Friday, reaching $70.42. The stock had a trading volume of 126,242 shares, compared to its average volume of 454,252. The company has a market capitalization of $3.62 billion, a price-to-earnings ratio of 56.34 and a beta of 0.41. Exponent has a 1-year low of $44.44 and a 1-year high of $72.70. The stock’s 50 day simple moving average is $70.12 and its two-hundred day simple moving average is $62.50. The company has a debt-to-equity ratio of 0.05, a current ratio of 3.60 and a quick ratio of 3.60.
The firm also recently announced a quarterly dividend, which was paid on Friday, September 20th. Shareholders of record on Friday, September 6th were given a dividend of $0.16 per share. The ex-dividend date was Thursday, September 5th. This represents a $0.64 dividend on an annualized basis and a yield of 0.91%. Exponent’s dividend payout ratio is presently 51.20%.
In other Exponent news, insider John Pye sold 3,000 shares of Exponent stock in a transaction that occurred on Friday, August 9th. The shares were sold at an average price of $70.31, for a total transaction of $210,930.00. Following the transaction, the insider now directly owns 25,747 shares of the company’s stock, valued at $1,810,271.57. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Harri Kytomaa sold 2,000 shares of Exponent stock in a transaction on Tuesday, August 13th. The shares were sold at an average price of $70.09, for a total transaction of $140,180.00. Following the completion of the sale, the insider now owns 9,399 shares in the company, valued at approximately $658,775.91. The disclosure for this sale can be found here. Insiders have sold 102,773 shares of company stock valued at $7,227,536 in the last quarter. Company insiders own 2.30% of the company’s stock.
Several hedge funds have recently made changes to their positions in the company. BlackRock Inc. raised its position in Exponent by 0.3% in the 2nd quarter. BlackRock Inc. now owns 7,548,049 shares of the business services provider’s stock worth $441,864,000 after buying an additional 24,045 shares during the last quarter. Conestoga Capital Advisors LLC increased its stake in shares of Exponent by 4.4% during the second quarter. Conestoga Capital Advisors LLC now owns 2,422,012 shares of the business services provider’s stock valued at $141,785,000 after buying an additional 102,845 shares during the period. FMR LLC boosted its position in Exponent by 39.8% during the first quarter. FMR LLC now owns 993,288 shares of the business services provider’s stock valued at $57,333,000 after purchasing an additional 282,530 shares in the last quarter. Geode Capital Management LLC boosted its position in Exponent by 9.6% during the fourth quarter. Geode Capital Management LLC now owns 648,674 shares of the business services provider’s stock valued at $32,893,000 after purchasing an additional 56,600 shares in the last quarter. Finally, Nuveen Asset Management LLC bought a new stake in Exponent during the second quarter valued at about $34,946,000. Hedge funds and other institutional investors own 88.08% of the company’s stock.
Exponent Company Profile
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation.
Recommended Story: What is insider trading?
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.